medication
Patients Stop Medication Due to Emotional, Identity Struggles
Patients stop medication due to emotional and identity struggles, revealing a complex reality beyond side effects or forgetfulness.
Subcutaneous Efgartigimod Improves Ocular Myasthenia Symptoms
Subcutaneous efgartigimod significantly improves ocular myasthenia symptoms, with III ADAPT OCULUS data showing less double vision and drooping eyelids.
Oral diabetes drug proves heart-safe in study
New oral diabetes drug orforglipron (Foundayo) proves heart-safe in study, meeting cardiovascular safety standards compared to insulin glargine.
Trump picks Overton to head FDA
President Trump appoints physician Heidi Overton as the new FDA commissioner to oversee drug approvals and health regulations.
Users Alarmed After Platform Announces Blocking Policy
Vitamin D deficiency linked to kidney disease affects bone health, blood pressure, immune function and survival, revealing a critical public health issue.
User access restricted after policy breach
The FDA approved Simtriyo, a new ADHD medication for adults and children, improving focus and emotional regulation with extended-release benefits.